Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: |
Title | Proniras |
Description | Home Toggle navigation About Team Investors News Contact Home Proniras Corporation is a specialty pharmaceutical company focused on developing therapies for th |
Keywords | N/A |
WebSite | proniras.com |
Host IP | 107.180.28.42 |
Location | United States |
Site | Rank |
US$1,592
Last updated: 2023-05-18 18:47:00
proniras.com has Semrush global rank of 0. proniras.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. proniras.com receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 107.180.28.42. According to SiteAdvisor, proniras.com is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
proniras.com. | A | 7200 | IP: 107.180.28.42 |
proniras.com. | NS | 7200 | NS Record: ns24.worldnic.com. |
proniras.com. | NS | 7200 | NS Record: ns23.worldnic.com. |
proniras.com. | MX | 3600 | MX Record: 10 spam.emberone.com. |
proniras.com. | MX | 3600 | MX Record: 90 spambackup.emberone.com. |
proniras.com. | TXT | 3600 | TXT Record: MS=ms98772236 |
proniras.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spam.emberone.com -all |
Toggle navigation About Team Investors News Contact Home Proniras Corporation is a specialty pharmaceutical company focused on developing therapies for those fighting to overcome addiction. In the Press Proniras Corporation Announces National Institute on Drug Abuse (NIDA) Grant Award to Pursue Treatment for Opioid Withdrawal Click Here Accelerator Life Science Partners Launches Proniras Corporation to Support Development of Tezampanel in the Treatment of Seizure Disorders Click Here Proniras Corporation Awarded Contract Worth Up to $89.5 Million from U.S. Biomedical Advanced Research and Development Authority to Develop Tezampanel as a Medical Countermeasure for Nerve Agent-Induced Seizures Click Here © Proniras Financial Conflict of Interest Policy |
Domain Name: PRONIRAS.COM Registry Domain ID: 2101720127_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-01-01T09:23:45Z Creation Date: 2017-03-02T18:12:17Z Registry Expiry Date: 2023-03-02T18:12:17Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS23.WORLDNIC.COM Name Server: NS24.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-07-14T09:02:39Z <<< |